Revealing and targeting metabolic drivers contributing to treatment escape in diffuse midline glioma

被引：0
|
作者：
Frederico, Stephen C.
Neyazi, Sina
Gowda, Pruthvi
Cuong Nguyen
Trissal, Maria
Portero, Erika P.
Haley-Read, John-Paul
Anderson, Emily P.
Thomas, Craig J.
Danial, Nika N.
Filbin, Mariella G.
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Natl Ctr Adv Translat Sci, Div Preclin Innovat Chem Technol, NIH, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10038
引用
收藏
页数：1
相关论文
共 50 条
  • [31] SAFELY TARGETING GD2 IN THALAMIC DIFFUSE MIDLINE GLIOMA WITH MRNA CAR T CELLS
    Foster, Jessica
    Griffin, Crystal
    Stern, Allison
    Madsen, Peter
    Storm, Phillip
    Resnick, Adam
    NEURO-ONCOLOGY, 2022, 24 : 86 - 86
  • [32] Targeting H3.3 serine 28 phosphorylation as a novel therapeutic strategy for diffuse midline glioma
    Yan, Yuqian
    CANCER RESEARCH, 2024, 84 (06)
  • [33] TARGETING GD2 IN THALAMIC DIFFUSE MIDLINE GLIOMA WITH TRANSIENT MRNA CAR T CELLS
    Foster, Jessica
    Madsen, Peter
    Harvey, Kyra
    Patterson, Luke
    Griffin, Crystal
    Stern, Allison
    Storm, Phillip
    Resnick, Adam
    NEURO-ONCOLOGY, 2023, 25
  • [34] THE BIG AND SMALL OF PROTEIN POST-TRANSLATIONAL MODIFICATIONS: TARGETING SUMOYLATION AND CITRULLINATION IN DIFFUSE MIDLINE GLIOMA
    Rayner, Benjamin S.
    Samadder, Arjayeeta
    Holliday, Holly
    Chen, Yongjuan
    Nguyen, Hieu
    Lee, Alvin
    Liu, Jie
    Hayden, Elisha
    Ogunmodede, Oluwaseyi S.
    Rye, Kerry-Anne
    Tsoli, Maria
    Bertoldo, Jean B.
    Ziegler, David S.
    NEURO-ONCOLOGY, 2024, 26
  • [35] THERAPEUTIC TARGETING OF CROSSTALK BETWEEN MITOCHONDRIAL FITNESS AND CELL ADHESION/MIGRATION IN DIFFUSE MIDLINE GLIOMA (DMG)
    Cartaxo, Rodrigo
    Ji, Sunjong
    Schwark, Kallen
    Koschmann, Carl
    NEURO-ONCOLOGY, 2023, 25
  • [36] VAL-083 IN COMBINATION WITH AZD1775 FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
    Subramaniam, Bavani
    Roy, Debasish
    Woldegerima, Ayda
    Przystal, Justyna
    Zhang, Jie
    Laternser, Sandra
    Kritzer, Bettina
    Yadavilli, Sridevi
    Mueller, Sabine
    Packer, Roger
    Nazarian, Javad
    NEURO-ONCOLOGY, 2024, 26
  • [37] PEMBROLIZUMAB AS SALVAGE TREATMENT IN CHILDREN WITH RECURRENT DIFFUSE MIDLINE GLIOMA: REPORT OF THREE CASES
    Lee, Yi-Yen
    Chen, Hsin-Hung
    Chen, Yi-Wei
    Chang, Fang-Chi
    Lin, Shih-Chieh
    Liang, Muh-Lii
    NEURO-ONCOLOGY, 2018, 20 : 99 - 99
  • [38] Tenascin-C as a Biomarker of Tumorigenesis and Treatment Response in Pediatric Diffuse Midline Glioma
    Saratsis, Amanda Muhs
    Qi, Jin
    Huang, Tina
    Ozark, Patrick
    Hashizume, Rintaro
    Bartom, Elizabeth
    James, Charles
    Shilatifard, Ali
    Saratsis, Amanda
    JOURNAL OF NEUROSURGERY, 2019, 131 (01)
  • [39] Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab
    Yong Wang
    Jun Xu
    Ningning Luo
    Chuang Qi
    Rongjie Tao
    Investigational New Drugs, 2021, 39 : 1432 - 1435
  • [40] Preclinical assessment of the safety and efficacy of targeting N-terminal histone tails in combination with emerging therapeutics for the treatment of diffuse midline glioma
    Sinclair, Maddison R.
    Jackson, Evangeline R.
    Mannan, Abdul
    Douglas, Alicia
    Duchatel, Ryan J.
    Dun, Matthew D.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 37 - 37
12345